Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

19.12
+0.40002.14%
Pre-market: 19.190.0700+0.37%06:23 EDT
Volume:1.57M
Turnover:29.93M
Market Cap:3.72B
PE:-38.18
High:19.24
Open:18.73
Low:18.58
Close:18.72
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:193.53M
Volume Ratio:0.73
T/O Rate:0.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:3.02
PE(LYR):-11.80

Loading ...

Legend Biotech Q2 FY26 Turns to Net Income of $33.2 Million; Revenue Rises 51.9% to $387.5 Million Year over Year

Reuters
·
Aug 11

Legend Biotech Q2 Adj. EPS $0.16 Beats $0.07 Estimate, Sales $387.500M Beat $355.772M Estimate

Benzinga Earnings
·
Aug 11

Legend Biotech Corporation - Carvykti Net Trade Sales Increase 50% in Q2 2026 to $657 Mln

THOMSON REUTERS
·
Aug 11

Legend Biotech Corporation Q2 Adjusted EPS USD 0.16 VS. Ibes Estimate USD 0.07

THOMSON REUTERS
·
Aug 11

Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights

THOMSON REUTERS
·
Aug 11

After Multiple Bearish Catalysts, Legend Biotech's Stock Halved in Two Months: Value Trap or Bargain Opportunity?

Stock News
·
Aug 11

Top News Today/Canada: Barrick Settles Newmont Dispute, Clearing Way to List Its Gold Assets

Dow Jones
·
Aug 11

Legend Biotech Corporation Expected to Post Earnings of 7 Cents a Share - Earnings Preview

Reuters
·
Aug 08

Earning Preview: Legend Biotech this quarter’s revenue is expected to increase by 55.36%, and institutional views are positive

Earnings Agent
·
Aug 05

Legend Biotech Interim CEO Alan Bash Files Initial Beneficial Ownership Statement

Reuters
·
Aug 04

Legend Biotech (LEGN) CEO Exit Raises Questions, Is The Stock Still Cheap?

Simply Wall St.
·
Jul 31

Legend Biotech to Host Investor Call on Second-quarter 2026 Results

Reuters
·
Jul 28

Legend Biotech Corp : Raymond James Cuts Target Price to $58 from $86

THOMSON REUTERS
·
Jul 28

Legend Biotech Price Target Maintained with a $65.00/Share by HC Wainwright & Co.

Dow Jones
·
Jul 28

Buy Rating Reiterated as Strong CARVYKTI Momentum and Attractive Valuation Support Unchanged $65 Price Target

TIPRANKS
·
Jul 28

Under the Radar: Legend Stock Tumbles After CEO's Abrupt Departure

Dow Jones
·
Jul 28

Legend Biotech's In Vivo CAR-T Cell Therapy Data Validates Approach, RBC Capital Markets Says

MT Newswires Live
·
Jul 27

Legend Biotech is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 27

Legend Biotech falls -12.5%

TIPRANKS
·
Jul 27

Legend Biotech price target lowered to $59 from $63 at RBC Capital

TIPRANKS
·
Jul 27